Onconetix shareholders approve reverse stock split up to 1-for-10

Onconetix, Inc.

• Reverse split proposal approved with 1,301,918 for, 253,378 against, 1,393 abstentions.
• Board may implement one or more splits at ratios between 1:2 and 1:10 within one year, not exceeding 1:100 aggregate.
• Adjournment proposal also approved with 1,332,088 for, 223,071 against, 1,530 abstentions.
• Reverse split authorized without further stockholder approval; exact ratio to be set by the board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.